ClinicalTrials.gg
CompletedNCT00350285TMCU3Updated Oct 23, 2008

The Teen Marijuana Check-Up

A Phase 2 interventional study of Motivational enhancement therapy and Marijuana education in Cannabis Abuse and Cannabis Dependence, sponsored by University of Washington. Completed. Open to participants aged 14 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-10-23.

Sponsored by University of Washington · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
310
Allocation
Randomized
Ages
14 Years to 19 Years
Sex
All
01

Study summary

This behavioral research is an efficacy trial evaluating an intervention called "The Teen Marijuana Check-Up" with non-treatment seeking adolescent marijuana users.

Read the detailed description

Three hundred adolescents who smoke marijuana (ages 14-19), recruited in four Seattle-area high schools, will be enrolled in the trial. Participants will be recruited either through in-class presentations focusing on marijuana or via referrals from school staff. They will first be assessed regarding use of marijuana, alcohol, and other drugs, as well as pertinent attitudes and goals. Participants will then be randomly assigned to one of three conditions.

  • The experimental intervention is a two-session motivational enhancement treatment. A personalized feedback report, containing information from the participant's assessment as well as normative comparison data, is reviewed, with the Health Educator employing motivational interviewing strategies intended to enhance motivation for reduction or cessation of marijuana use. Specific goals for change and behavior change strategies are discussed with participants who wish support to change their marijuana use.
  • The comparison condition involves two educational sessions focusing on the health and behavioral effects of marijuana.
  • The third condition (delayed treatment control) involves a minimal baseline assessment followed three months later by a reassessment interview. Those assigned to this condition will then be given their choice of either active treatment.

Following completion of their two intervention sessions, participants in the two active treatments will be offered an additional four sessions of cognitive-behavioral skills training in which the focus is strategies in quitting marijuana. All participants will be reassessed at 3 and 12 months following their initial assessment interviews.

02

Conditions studied

  • Cannabis Abuse
  • Cannabis Dependence

Browse trials for

Keywords

  • cannabis
  • marijuana
03

In context

Marijuana Abuse

530 studies on the registry are indexed under Marijuana Abuse; 113 are open to participants now.

This study's enrollment of 310 is above the median of 60 across 431 interventional studies indexed under Marijuana Abuse.

Browse Marijuana Abuse studies →

Lead sponsor

University of Washington is the lead sponsor of 1,431 studies on the registry; 226 are open to participants now.

Of its 158 completed or terminated interventional studies of FDA-regulated products, 136 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Individuals who contact the project will be screened according to the following inclusion criteria:

  • age (14-19 years old),
  • grade level (freshmen through seniors) and
  • marijuana use (smoked 9 or more days in past 30).

Exclusion Criteria: Individuals will be excluded if:

  • they are not fluent in English,
  • they have a thought disorder that precludes full participation,
  • they refuse to accept randomization to condition.

In addition to the inclusion and exclusion criteria, participants who appear to be in psychological or physical distress will be assessed further and referred to other services as appropriate. The need for other services will not necessarily preempt participation in the TMCU unless the individual is incapable or unwilling to complete the protocol. As was the case in our Stage 1b trial, all ineligible applicants will be offered a single feedback session, and the Strategies That Work booklet will be offered to those who indicate any interest in reducing or quitting marijuana use.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
310 participants (actual)

Study arms

  • Experimental
    1

    Motivational enhancement therapy

    Behavioral: Motivational enhancement therapy

  • Active comparator
    2

    Marijuana education

    Behavioral: Marijuana education

  • No intervention
    3

    Delayed treatment control condition

Interventions

  • BehavioralMotivational enhancement therapy

    Personal feedback with counselor using motivational interviewing strategies.

  • BehavioralMarijuana education

    Information about health and behavioral effects of marijuana use.

06

What researchers measure

Primary outcomes

  1. Self-report of marijuana use

    Time frame: 3 months and 12 months

Secondary outcomes

  1. Accepting abstinence-focused counseling

    Time frame: 3 months and 12 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00350285
First posted
Jul 10, 2006
Start date
Sep 2004
Primary completion
Jun 2008
Completion
Jun 2008
Last update
Oct 23, 2008

Study contacts

Roger A Roffman, DSW
principal investigator · University of Washington School of Social Work

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion